Status:
TERMINATED
Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH
Lead Sponsor:
IVI Madrid
Conditions:
Aneuploidy Rate
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Several stimulation protocols have been used in in vitro fertilization (IVF) in a cycle of egg donation; recombinant FSH and human FSH are included. The effect of each kind of hormone on aneuploidy ra...
Eligibility Criteria
Inclusion
- Egg donation cycles with more than 8MII in oocyte retrieval day
Exclusion
- Male factor
- Uterine malformations
- genetic alterations
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01164943
Start Date
July 1 2010
End Date
December 1 2012
Last Update
February 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Insituto Valenciano de Infertilida, Spain, Madrid
Madrid, Madrid, Spain, 28023